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Conclusions: SF derived markers are often used to monitor
tissue degradation in joint diseases such as Rheumatoid Arthri-
tis and Osteoarthritis. Monitoring of a single index joint is most
directly done by analysis of joint fluid. At times it becomes desir-
able to estimate synovial fluid volume to determine total amount
of biomarker in the joint. This may be of special use in cases of
acute inflammation with effusion. Urea is a small molecule (60
Da) which readily diffuses between blood and synovial fluid. It is
neither metabolised nor produced by any joint tissue. Our urea
results for direct aspirates indicates an equilibrium state between
serum and SF with regard to the water fraction. This equilibrium
exists regardless of disease status (KL grade), inflammation (cell
count), or age, making it possible to calculate intraarticular vol-
ume of lavaged joints based upon this urea method. Most of the
joint volumes we calculated fell within the previously reported
range for normal knees of 0.5-4ml. The positive correlation be-
tween SF volume and knee symptoms provides independent
confirmation of the recently reported association of knee pain
and stiffness with moderate and large joint effusions by magnetic
resonance imaging. This correlation reinforces the clinical utility
of this method for quantifying SF volume.
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Purpose: The objective of this study was to measure serum and
urine biomarkers indicative of joint pathology in participants en-
rolled in the Genetics of Generalized Osteoarthritis (GoGo) study,
to determine change in biomarkers relative to OA disease sever-
ity and progression as determined by change in radiographic
status.
Methods: Participants were selected based on radiographic ev-
idence considered to be indicative of mild to moderate OA in
the knees, as determined by Kellgren Lawrence grade (KL grade
1, 2, 3) and having a minimum joint space (MJS) of ≥0.5mm.
Osteophytes (Os) and joint space narrowing were scored (0-3)
using a standard atlas. Serum and urine markers were mea-
sured in a total of 517 subjects at 2 time-points, ranging between
2-5 years since baseline. Markers measured included, sCOMP,
sHA, uCTXII (normalized to urine creatinine for standardization),
sPIIANP, uCreatinine, uNTX, s846, xCPII, and serum hsCRP.
All biomarker data were log transformed. For each biomarker
and radiographic variable, the change is defined to be the dif-
ference between follow-up and baseline measures. Disease pro-
gression is defined as a positive change in any radiographic
measures.
Statistics: Participants with KL grades 3 or 4 in either hip at
baseline or with knee lateral minimum joint space (at base-
line or follow-up) of less than 3mm were excluded. Analysis
was conducted on the remaining 474 subjects. Radiographic
measurements of interest were summed from both knees and
hips. Parameters of interest included KL-Grades, Os scores
and JSN. Of interest are the relationships between 1) base-
line biomarker and baseline radiographic data, 2) between the
change in biomarker and baseline radiographic data, and 3)
between change in biomarker and radiographic OA progres-
sion. Simple linear regression was used to explore relationships
between biomarker and radiographic variables; Pearson’s corre-
lation coefficients are reported.
Results: Significant Pearson’s correlations were observed with
baseline sHA and uCTXII, markers of inflammation and collagen
degradation (Table) with respect to Os, JSN and KL grade.
Correlations with the remainder of the biomarkers were not
significant.
Differences in correlation between sHA and KL grade were
observed to be stronger among women, while the correlation be-
tween uCTXII and Os were stronger in men. Correlation between
sHA and Os is positive for females, but negative for males.
Baseline Sum
KL Grade OS NAR n
Baseline log_uCTXIIb ALL 0.169* 0.180** 0.131* 224
Females 0.182* 0.129 0.140 179
Males 0.114 0.324** 0.098 49
Baseline log sHab All 0.239**** 0.106 0.259**** 288
Females 0.252*** 0.174** 0.258*** 232
Males 0.158 -0.156 0.236 57
*p<0.05, **p<0.01, ***p <0.005, ****p <0.001.
Baseline uCTXII and change in JSN were correlated (r=0.147;
p<0.05), with correlation among females (males) being r = 0.201
(r = -0.069). Baseline sHa and change in JSN were correlated
(r = 0.160, p < 0.005); similar correlations were observed when
males and females were evaluated separately. When considering
the correlations between change in biomarkers and change in
radiographic parameters, a significant correlation was observed
in the change in uCTXII and change in JSN in males, r = 0.290.
Conclusions: Findings suggest that baseline biomarker levels
are reflective of radiographically determined disease severity and
progression, with observed gender differences.
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Purpose: To investigate whether patients with increased urinary
levels of type II collagen C-telopeptide (UCTX-II) at baseline
have an elevated risk to develop radiographic progression of
osteoarthritis (OA) in the knee after two years.
Methods: 208 patients (104 sibling pairs) from the Genetics,
Artrosis and Progression study (GARP), with symptomatic famil-
ial OA at multiple joint sites, were followed for two years. UCXT-II
levels were measured with an enzyme-linked immunosorbent
assay at baseline. Radiographs were taken at baseline and af-
ter two years. Knee OA was diagnosed when the Kellgren and
Lawrence score of one or both knees was equal to or larger than
two, or if the joint had been replaced by arthroplasty. Two ex-
perienced readers scored the paired radiographs conservatively
in consensus with the chronological order unknown. Joint space
narrowing (JSN) was scored using the OARSI atlas and graded
on a scale of 0 to 3 (0 = normal joint space to 3 = maximum
JSN). The JSN scores in the medial en lateral compartment
in both knees were summated. We defined progression as a
minimum of one point increase in total JSN score in patients
